Baolingbao Biology Co Ltd Financial Flexibility Index
Baolingbao Biology Co Ltd financial flexibility index. Baolingbao Biology Co Ltd (002286) has a Financial Flexibility Index of 0.33x as of September 2025. Free cash flow of CN¥177.26 Million (operating CF CN¥134.96 Million minus capex CN¥42.30 Million) represents 0% of total liabilities (CN¥532.41 Million). See 002286 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Baolingbao Biology Co Ltd (2006–2025)
Financial flexibility index of Baolingbao Biology Co Ltd from 2006 to 2025. Historical Financial Flexibility Index trend for Baolingbao Biology Co Ltd across 20 annual periods. Check Baolingbao Biology Co Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Baolingbao Biology Co Ltd Financial Flexibility Index by Year (2006–2025)
Baolingbao Biology Co Ltd financial flexibility index by year from 2006 to 2025. Year-by-year free cash flow to debt coverage for Baolingbao Biology Co Ltd. For the full cash flow conversion analysis, see Baolingbao Biology Co Ltd (002286) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.82x | CN¥448.66 Million | CN¥259.36 Million | CN¥547.81 Million | ▲ +18.1% |
| 2024 | 0.69x | CN¥438.65 Million | CN¥248.72 Million | CN¥632.44 Million | ▲ +7.8% |
| 2023 | 0.64x | CN¥434.51 Million | CN¥282.28 Million | CN¥675.41 Million | ▲ +125.8% |
| 2022 | 0.28x | CN¥285.37 Million | CN¥30.82 Million | CN¥1.00 Billion | ▲ +15.8% |
| 2021 | 0.25x | CN¥299.11 Million | CN¥206.27 Million | CN¥1.22 Billion | ▼ -52.9% |
| 2020 | 0.52x | CN¥530.39 Million | CN¥398.46 Million | CN¥1.02 Billion | ▲ +99.1% |
| 2019 | 0.26x | CN¥249.41 Million | CN¥153.95 Million | CN¥951.76 Million | ▼ -11.4% |
| 2018 | 0.30x | CN¥306.76 Million | CN¥133.05 Million | CN¥1.04 Billion | ▲ +177.3% |
| 2017 | 0.11x | CN¥62.05 Million | CN¥-36.91 Million | CN¥581.79 Million | ▼ -78.0% |
| 2016 | 0.49x | CN¥205.51 Million | CN¥108.98 Million | CN¥423.43 Million | ▼ -23.7% |
| 2015 | 0.64x | CN¥276.88 Million | CN¥77.49 Million | CN¥435.44 Million | ▼ -46.3% |
| 2014 | 1.18x | CN¥374.68 Million | CN¥101.77 Million | CN¥316.69 Million | ▲ +22.3% |
| 2013 | 0.97x | CN¥233.06 Million | CN¥85.60 Million | CN¥240.88 Million | ▲ +76.8% |
| 2012 | 0.55x | CN¥161.65 Million | CN¥94.15 Million | CN¥295.31 Million | ▼ -36.6% |
| 2011 | 0.86x | CN¥304.01 Million | CN¥171.70 Million | CN¥352.06 Million | ▲ +51.1% |
| 2010 | 0.57x | CN¥188.27 Million | CN¥27.45 Million | CN¥329.46 Million | ▲ +74.5% |
| 2009 | 0.33x | CN¥138.02 Million | CN¥44.51 Million | CN¥421.50 Million | ▼ -8.1% |
| 2008 | 0.36x | CN¥180.28 Million | CN¥110.77 Million | CN¥505.85 Million | ▼ -53.1% |
| 2007 | 0.76x | CN¥310.67 Million | CN¥78.98 Million | CN¥408.62 Million | ▲ +792.6% |
| 2006 | 0.09x | CN¥33.68 Million | CN¥19.12 Million | CN¥395.40 Million | — |